Business Description
![Hofseth BioCare ASA Hofseth BioCare ASA logo](https://static.gurufocus.com/logos/0C00009542.png?14)
Hofseth BioCare ASA
NAICS : 325412
SIC : 2834
ISIN : NO0010598683
Compare
Compare
Traded in other countries / regions
HBC.NorwayHBCO.SwedenHOFBF.USAHBQ.Germany0Q6H.UK IPO Date
2018-08-02Description
Hofseth BioCare ASA is a Norway based company engaged in the business of development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. It is also involved in cooperation, participation, and ownership in the businesses engaged in related activities. The group operates in the business segment of producing salmon oil, soluble protein, calcium, and nonwater soluble protein. The brands under the company are OmeGo, PetGo, ProGo, and CalGo. The firm sells products to various segments of the human nutrition market such as sports nutrition, supplements, and health foods, as well as to the market within nutrition to pet and feed industry. It generates the majority of the revenue from the sale of salmon oil.
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.14 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 1.04 | |||||
Debt-to-EBITDA | -3.2 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.8 | |||||
Beneish M-Score | -3.48 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 33.3 | |||||
3-Year EBITDA Growth Rate | 7.1 | |||||
3-Year EPS without NRI Growth Rate | -2.1 | |||||
3-Year FCF Growth Rate | 56.3 | |||||
3-Year Book Growth Rate | -47.7 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 7.63 | |||||
9-Day RSI | 23.46 | |||||
14-Day RSI | 31.8 | |||||
6-1 Month Momentum % | -18.18 | |||||
12-1 Month Momentum % | -82 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.99 | |||||
Quick Ratio | 0.39 | |||||
Cash Ratio | 0.16 | |||||
Days Inventory | 257.97 | |||||
Days Sales Outstanding | 32.01 | |||||
Days Payable | 356.02 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.4 | |||||
Shareholder Yield % | -5.41 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 31.97 | |||||
Operating Margin % | -57.75 | |||||
Net Margin % | -48.33 | |||||
FCF Margin % | -13.95 | |||||
ROE % | -93.44 | |||||
ROA % | -24.65 | |||||
ROIC % | -36.95 | |||||
ROC (Joel Greenblatt) % | -50.23 | |||||
ROCE % | -45.61 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.98 | |||||
PB Ratio | 5.1 | |||||
Price-to-Tangible-Book | 9 | |||||
EV-to-EBIT | -10.51 | |||||
EV-to-EBITDA | -18.44 | |||||
EV-to-Revenue | 4.64 | |||||
EV-to-FCF | -33.52 | |||||
Price-to-Median-PS-Value | 0.43 | |||||
Earnings Yield (Greenblatt) % | -9.51 | |||||
FCF Yield % | -3.51 |